Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate

In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation

(2017) Carol A. McCarthy et al.   JOURNAL OF CONTROLLED RELEASE

Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS

(2016) A.-L. Lainé et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

In Vivo Performance of Fenofibrate Formulated With Ordered Mesoporous Silica Versus 2-Marketed Formulations: A Comparative Bioavailability Study in Beagle Dogs

(2016) Katarina Bukara et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments

(2015) Joseph P. O’Shea et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Mesoporous silica formulation strategies for drug dissolution enhancement: a review

(2015) Carol A. McCarthy et al.   Expert Opinion on Drug Delivery

Mesoporous silica-based dosage forms improve release characteristics of poorly soluble drugs: case example fenofibrate

(2015) Jennifer B. Dressman et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects

(2014) Erik Sjögren et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro–in silico–in vivo approach

(2013) Yang Fei et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: Case studies with fenofibrate

(2013) Brendan T. Griffin et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Use of Ordered Mesoporous Silica to Enhance the Oral Bioavailability of Ezetimibe in Dogs

(2011) Filip Kiekens et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica

(2010) Michiel Van Speybroeck et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole

(2010) Michiel Van Speybroeck et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles

(2010) Daniel Juenemann et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility

(2010) Dallas B. Warren et al.   JOURNAL OF DRUG TARGETING

Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?

(2009) Joachim Brouwers et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Ordered Mesoporous Silica Material SBA-15: A Broad-Spectrum Formulation Platform for Poorly Soluble Drugs

(2008) Michiel Van Speybroeck et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update

(2008) Ekarat Jantratid et al.   PHARMACEUTICAL RESEARCH

Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica

(2007) Randy Mellaerts et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Mesoporous Silicon in Drug Delivery Applications

(2007) Jarno Salonen et al.   JOURNAL OF PHARMACEUTICAL SCIENCES